Goldman Sachs initiated coverage on U.S.-listed generic pharmaceutical companies with Buy ratings on Teva Pharmaceutical Industries (NYSE:TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX), and a Neutral ...

Waldron said in a podcast that Goldman Sachs is absorbing a “lot of risk” from its clients, but wherever possible, it is ...

The job market has stayed resilient, defying fears of tariffs causing a slowdown.

Asian equities attracted strong foreign inflows in May as concerns over an immediate economic hit from higher U.S. tariffs ...

Job gains for March and April were revised down by a combined 95,000, portraying a weaker labor market that believed in late ...

In May, job gains were especially strong in the health care, leisure and hospitality, and social assistance sectors. However federal government employment declined by 22,000 in May and is now down by ...

GPIX combines S&P 500 exposure with dynamic covered calls for income and downside support, but faces near-term pressure. Find ...

Nonfarm payrolls rose 139,000 for the month, above the Dow Jones estimate for 125,000 and a bit below the downwardly revised 147,000 in April. The unemployment rate held at 4.2%. Worker pay grew more ...

President Donald Trump confirmed on Friday that three of his top officials will meet with Chinese government representatives ...

Job gains for March and April were revised down by a combined 95,000, portraying a weaker labor market than believed in late winter and early spring. March's total was downgraded from 185,000 to ...

The dollar is struggling, and strategists overwhelmingly agree it’s heading even lower. But with such strong consensus on a ...

U.S. job growth likely slowed considerably in May as businesses struggled with headwinds from tariff uncertainty, but ...